Pharmaceuticals news FT.com

AstraZeneca to invest $2.5bn in China after scandal

London-listed drugmaker will establish research centre in Beijing

Mar 21, 2025 - 12:37
 0
AstraZeneca to invest $2.5bn in China after scandal
London-listed drugmaker will establish research centre in Beijing
Read More

Tags:

Previous Article

Lee's Summit development looks to grow but preserve, respond but prepare

Next Article

Australian F/A-18F Live Fires AGM-158C LRASM

Related Posts

GSK struggles to convince market it can deliver on pipeline plans

GSK struggles to convince market it can deliver on pipe...

Feb 22, 2025  0

Manchester looks to build on life sciences cluster effect

Manchester looks to build on life sciences cluster effect

Mar 10, 2025  0

Ken Griffin’s Citadel bets £300mn against drugmaker GSK

Ken Griffin’s Citadel bets £300mn against drugmaker GSK

Feb 14, 2025  0